TY - JOUR
T1 - ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
AU - Adamina, M.
AU - Bonovas, S.
AU - Raine, T.
AU - Spinelli, A.
AU - Warusavitarne, J.
AU - Armuzzi, A.
AU - Bachmann, O.
AU - Bager, P.
AU - Biancone, L.
AU - Bokemeyer, B.
AU - Bossuyt, P.
AU - Burisch, J.
AU - Collins, P.
AU - Doherty, G.
AU - El-Hussuna, A.
AU - Ellul, P.
AU - Fiorino, G.
AU - Frei-Lanter, C.
AU - Furfaro, F.
AU - Gingert, C.
AU - Gionchetti, P.
AU - Gisbert, J.P.
AU - Gomollon, F.
AU - Lorenzo, M.G.
AU - Gordon, H.
AU - Hlavaty, T.
AU - Juillerat, P.
AU - Katsanos, K.
AU - Kopylov, U.
AU - Krustins, E.
AU - Kucharzik, T.
AU - Lytras, T.
AU - Maaser, C.
AU - Magro, F.
AU - Marshall, J.K.
AU - Myrelid, P.
AU - Pellino, G.
AU - Rosa, I.
AU - Sabino, J.
AU - Savarino, E.
AU - Stassen, L.
AU - Torres, J.
AU - Uzzan, M.
AU - Vavricka, S.
AU - Verstockt, B.
AU - Zmora, O.
AU - Akyuz, F.
AU - Atreya, R.
AU - De Acosta, M.B.
AU - Bettenworth, D.
AU - European Crohn’s Colitis Organisation (ECCO)
N1 - Funding Information:
We gratefully thank: Paul Freudenberger for the literature search and fulltext retrieval; Torsten Karge for the support on informatics and on the web Guidelines platform; and the ECCO Office for the logistical and coordination support. We gratefully thank the EFCCA patient representatives Ciara Drohan, Evelyn Gro, Sanna Lnnfors, and Marko Perovic who proactively collaborated in the development of these Guidelines. We would like to acknowledge the ECCO National Representatives who acted as external reviewers and reviewed and provided suggestions on the recommendations and supporting text to this document: Filiz Akyuz, Raja Atreya, Manuel Barreiro De Acosta, Dominik Bettenworth, Clas-Gran Bjrkesten, Ante Bogut, Emma Calabrese, Mirjana Cvetkovic, Pieter Dewint, Srdjan Djuranovic, David Drobne, Dana Duricov, Jrme Filippi, Christoph Hgenauer, Ioannis Kaimakliotis, Gediminas Kiudelis, Maria Klopocka, Ioannis Koutroubakis, Zeljko Krznaric, Hendrik Laja, Alexander Moschen, Gregor Novak, Alexander Potapov, Ilus Tuire, Svetlana Turcan, Willemijn van Dop, Fiona van Schaik, Ana Isabel Vieira, Stephanie Viennot, and Signe Wildt. We would also like to thank the additional reviewers of these Guidelines: Giorgos Bamias, Yago Gonzalez Lama, Marietta Iacucci, Anna Valeryevna Kagramanova, Jost Langhorst, Gaetano Luglio, Annick Moens, Nurulamin Noor, Iago Rodrguez-Lago, Gerhard Rogler, Simone Saibeni, Carsten Schmidt, Tony Tham, and Andres Yarur.
Funding Information:
This project was initiated, funded, and supported by the European Crohn’s and Colitis Organisation.
Publisher Copyright:
Copyright © 2019 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: [email protected].
PY - 2020/2/1
Y1 - 2020/2/1
N2 - This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of previous guidelines.
AB - This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of previous guidelines.
KW - anti-tnf therapy
KW - crohn's disease
KW - evidence-based consensus
KW - fecal diversion
KW - inflammatory bowel disease [ibd]
KW - inflammatory-bowel-disease
KW - intersphincteric fistula tract
KW - intraabdominal septic complications
KW - postoperative complications
KW - pouch-anal anastomosis
KW - surgery
KW - to-end anastomosis
KW - vedolizumab-treated patients
KW - INTERSPHINCTERIC FISTULA TRACT
KW - EVIDENCE-BASED CONSENSUS
KW - POSTOPERATIVE COMPLICATIONS
KW - inflammatory bowel disease [IBD]
KW - FECAL DIVERSION
KW - VEDOLIZUMAB-TREATED PATIENTS
KW - ANTI-TNF THERAPY
KW - Crohn's disease
KW - INTRAABDOMINAL SEPTIC COMPLICATIONS
KW - INFLAMMATORY-BOWEL-DISEASE
KW - TO-END ANASTOMOSIS
KW - POUCH-ANAL ANASTOMOSIS
U2 - 10.1093/ecco-jcc/jjz187
DO - 10.1093/ecco-jcc/jjz187
M3 - Article
C2 - 31742338
SN - 1873-9946
VL - 14
SP - 155
EP - 168
JO - Journal of Crohn's & Colitis
JF - Journal of Crohn's & Colitis
IS - 2
ER -